Skip to content
lifestyle.celebhomes.net
Author:
IN8bio, Inc
IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026
June 1, 2026
IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
May 14, 2026
IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer
February 10, 2026
IN8bio to Present at Upcoming Investor and Scientific Conferences in February
February 3, 2026
←
Previous Page
1
2